AVOLAC oral sol. 200 ml (Glass)

Therapeutic Class

Laxatives, Purgatives


1. Constipation (chronic constipation): In every case of chronic constipation, initial treatment should consist of a diet rich in fiber (vegetables, salads, fruits, supplements of linseeds, wheat germ etc.) a generous amount of liquids and much physical exercise. Avolac is only to be taken when these measures prove insufficient. 2. Intestinal flora disturbances: In damage to intestinal flora, following therapy with broad spectrum antibiotics, gall bladder diseases and intestinal diseases (colttis, diverticulosis, megacolon etc.) 3. Increased blood ammonia levels (hyperammonemia in hepatopathy, portal systemic encephalopathy, precoma, coma). 4. Diseases of the gums and the parodontic apparatus (paradontosis, bleeding from the gums, inflammation, dystrophy).

Chemical Composition

Lactulose USP 3.35 g / 5 ml ( 6.1.2020 )


200 ml / Bot

Dosage & Administration



Hypersensitivity to either galactose and/ or lactose, galactose-free diet. Gastro-cardiac symptom complex (heart problems stemming from the gastro-intestinal tract), suspected intestinal obstruction.

Side Effects

Occasionally flatulence can occur at the beginning of treatment, this is rapidly eliminated by reducing the dose and/ or taking the daily dose in several smaller individual portions spread over the course of the day. Overdosage can result in diarrhoea. In abuse: loss of electrolytes (primarilty Potassium):

Drug Interaction

The glycosidic effect of cardiac glycosides can be intensified by potassium deficiency in abuse.